| Identification | Back Directory | [Name]
2-Piperazineacetonitrile, 4-[(7S)-7-(8-chloro-1-naphthalenyl)-7,8-dihydro-2-[[(2S)-1-methyl-2-pyrrolidinyl]methoxy]-5H-pyrano[4,3-d]pyrimidin-4-yl]-1-(2-fluoro-1-oxo-2-propen-1-yl)-, (2S)- | [CAS]
2648584-48-7 | [Synonyms]
2-Piperazineacetonitrile, 4-[(7S)-7-(8-chloro-1-naphthalenyl)-7,8-dihydro-2-[[(2S)-1-methyl-2-pyrrolidinyl]methoxy]-5H-pyrano[4,3-d]pyrimidin-4-yl]-1-(2-fluoro-1-oxo-2-propen-1-yl)-, (2S)- | [Molecular Formula]
C32H34ClFN6O3 | [MOL File]
2648584-48-7.mol | [Molecular Weight]
605.1 |
| Hazard Information | Back Directory | [Uses]
Talorasib (compound 1-2) has antitumor activity[1]. | [References]
[1] Shanghai Yingli Pharmaceutical Co., Ltd. Preparation of oxygen-containing heterocyclic compounds as Ras inhibitor for prevention and/or treatment of Ras mediated diseases. China, CN115385923 A 2022-11-25 |
|
|